ADORA2A and coronary artery disorder: A decrease in basal A2A receptor expression has been found in patients with CAD, or subjects with a positive stress test [21,22,23] and a reduced fractional flow reserve (FFR), which has led to the analysis of A2AR expression and function being proposed as a prognostic biomarker of CAD severity [21].